Home › Funds › a16z Capital Management, L.L.C. › BIOA

a16z Capital Management, L.L.C. position in BIOA

BIOAGE LABS INC · Health Care

a16z Capital Management, L.L.C. reported holding 3,233,170 shares of BIOA (BIOAGE LABS INC) in its Q2 2026 13F filing — a position valued at US$79.2M, representing 0.56% of its reported portfolio and ranking #6 among its reported holdings. a16z Capital Management, L.L.C. has disclosed BIOA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)3.23M sh
Reported value held$79.24M
Portfolio Weight0.56%
First reportedQ3 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How a16z Capital Management, L.L.C.'s BIOA position evolved

a16z Capital Management, L.L.C. first disclosed a stake in BIOA in Q3 2024 at 3,013,975 shares (US$62.7M). The position peaked in Q2 2026 at 3,233,170 shares, worth US$79.2M. Across 8 filings, a16z Capital Management, L.L.C. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 3,233,170 shares valued at US$79.2M.

Quarter by quarter

QuarterSharesValueChange
Q3 2024 3.01M $62.69M New
Q4 2024 3.23M $18.72M Add
Q1 2025 3.23M $12.16M Hold
Q2 2025 3.23M $13.35M Hold
Q3 2025 3.23M $19.01M Hold
Q4 2025 3.23M $44.07M Hold
Q1 2026 3.23M $56.55M Hold
Q2 2026 3.23M $79.24M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIOA and 13F data

BIOA (BIOAGE LABS INC) is a Health Care company. 78 other funds we track also report a position in BIOA — the largest reported positions include Cormorant Asset Management, LP (US$58.6M), Sofinnova Investments, Inc. (US$56.2M), Octagon Capital Advisors LP (US$42.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIOA

All BIOA fund holders →

FAQ

How long has a16z Capital Management, L.L.C. held BIOA?

a16z Capital Management, L.L.C. has disclosed BIOA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is a16z Capital Management, L.L.C.'s current position in BIOA?

As of Q2 2026, a16z Capital Management, L.L.C. holds 3.23M shares of BIOA (BIOAGE LABS INC), valued at $79.24M, representing 0.56% of its reported portfolio and ranking #6.

Has a16z Capital Management, L.L.C. been buying or selling BIOA?

In the latest 13F filing (Q2 2026), a16z Capital Management, L.L.C. held unchanged its position in BIOA. The position peaked in Q2 2026 at 3.23M shares.

Which other funds hold BIOA?

Other major institutional holders of BIOA include Cormorant Asset Management, LP, Sofinnova Investments, Inc., Octagon Capital Advisors LP, among 78 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.